Clinical Trial Update: Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria [Phase 2]

View source ↗

Summary

A Phase 2 platform study evaluating the efficacy and safety of anti-malarial agents in participants with uncomplicated Plasmodium falciparum malaria has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Falciparum Malaria

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Uncomplicated Plasmodium Falciparum Malaria | Phase 2 | Status: COMPLETED